Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Pancreatic Neuroendocrine Tumor”

210 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 210 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT05528614
What this trial is testing

Evaluation of the Results of Simultaneous Pancreatic and Hepatic Resections for Metastatic Neuroendocrine Tumors.

Who this might be right for
Tumor of Pancreas
University Hospital, Strasbourg, France 51
Early research (Phase 1)Ended earlyNCT02943733
What this trial is testing

Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs

Who this might be right for
Neuroendocrine TumorsNeoplasmsCancer+1 more
University of Wisconsin, Madison 18
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Early research (Phase 1)Ended earlyNCT05831995
What this trial is testing

Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.

Who this might be right for
Advanced Solid TumorRAS MutationRAF Mutation+1 more
ABM Therapeutics Corporation 12
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT02307500
What this trial is testing

Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy

Who this might be right for
Pancreas CancerOvarian CancerMelanoma+4 more
Istituto Clinico Humanitas 82
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Early research (Phase 1)Looking for participantsNCT06663072
What this trial is testing

Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Pancreatic Neuroendocrine Tumor
University of Chicago 25
Testing effectiveness (Phase 2)Study completedNCT02713763
What this trial is testing

Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib

Who this might be right for
Pancreatic Neuroendocrine Tumour Metastatic
Grupo Espanol de Tumores Neuroendocrinos 11
Post-approval studies (Phase 4)Study completedNCT02842749
What this trial is testing

Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

Who this might be right for
Pancreatic Neuroendocrine Tumors
Novartis Pharmaceuticals 61
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Not applicableLooking for participantsNCT06753136
What this trial is testing

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Who this might be right for
Primary Visceral Tumors of Any HistotypeVisceral LesionsLiver Cancer+9 more
Istituto Oncologico Veneto IRCCS 24
Not applicableLooking for participantsNCT06246630
What this trial is testing

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Advanced Pancreatic Neuroendocrine Tumor
Ruijin Hospital 20
Not applicableNot Yet RecruitingNCT07014254
What this trial is testing

Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Adenocarcinoma of the StomachColorectal Cancer Metastatic+1 more
Xijing Hospital 20
Early research (Phase 1)Looking for participantsNCT05076760
What this trial is testing

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+7 more
Memgen, Inc. 40
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Load More Results